140690-56-8

Basic information

• Product Name: 2,4-Bis(trifluoromethyl)benzyl bromide
• Synonyms: 1-(BROMOMETHYL)-2,4-BIS(TRIFLUOROMETHYL)BENZENE;2,4-DI(TRIFLUOROMETHYL)BENZYL BROMIDE;2,4-BIS(TRIFLUOROMETHYL)BENZYL BROMIDE;2,4-Bis(trifluoromethyl)benzyl bromide, 97+%;Benzene, 1-(bromomethyl)-2,4-bis(trifluoromethyl)-;2,4-Bis(trifluoromethyl)benzyl bromide 98%;2,4-Bis(trifluoromethyl)benzylbromide98%
• CAS NO: 140690-56-8
• Molecular Formula: C₉H₅BrF₆
• Molecular Weight: 307.03
• EINECS: -0
• Product Categories: Fluorine series
• Mol File: 140690-56-8.mol

Chemical Properties

• Boiling Point: 112°C 0,2mm
• Flash Point: 130 °F
• Appearance: Clear colorless to pale yellow/Liquid
• Density: 1.637 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.972mmHg at 25°C
• Refractive Index: n20/D 1.451(lit.)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• Sensitive: Lachrymatory
• BRN: 7995492
• CAS DataBase Reference: 2,4-Bis(trifluoromethyl)benzyl bromide(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-Bis(trifluoromethyl)benzyl bromide(140690-56-8)
• EPA Substance Registry System: 2,4-Bis(trifluoromethyl)benzyl bromide(140690-56-8)

Safety Data

• Hazard Codes: C
• Statements: 10-34
• Safety Statements: 16-26-27-36/37/39-45
• RIDADR: UN 2920 8/PG 2
• WGK Germany: 3
• HazardClass: 3
• PackingGroup: III
• Hazardous Substances Data: 140690-56-8(Hazardous Substances Data)

Usage

Uses

Different sources of media describe the Uses of 140690-56-8 differently. You can refer to the following data:
1. 2,4-Bis(trifluoromethyl)benzyl bromide may be used in chemical synthesis studies.
2. 2,4-Bis(trifluoromethyl)benzyl Bromide (CAS# 140690-56-8) can be used to cure elastomers with the use of inducers.

InChI:InChI=1/C9H5BrF6/c10-4-5-1-2-6(8(11,12)13)3-7(5)9(14,15)16/h1-3H,4H2

Downstream Products

• 796844-14-9 4-((2,4-bis(trifluoromethyl)benzyl)oxy)-3-methoxybenzaldehyde 
• 1422127-89-6 C₂₂H₂₁F₆N₃OS 
• 1422127-95-4 N²-[(5Z)-5-({1-[2,4-bis(trifluoromethyl)benzyl]piperidin-4-yl }methylidene)-2-oxo-2,5-dihydro-1,3-thiazol-4-yl]glycinamide 
• 1422127-97-6 (5Z)-5-({1-[2,4-bis(trifluoromethyl)benzyl]piperidin-4-yl}methylidene)-4-[(isoxazol-3-ylmethyl)amino]-1,3-thiazol-2(5H)-one 
• 1422127-98-7 (5Z)-5-({1-[2,4-bis(trifluoromethyl)benzyl]piperidin-4-yl}methylidene)-4-{[3-(2-oxopyrrolidin-1-yl)propyl]amino}-1,3-thiazol-2(5H)-one 
• 1422128-05-9 ethyl N-[(5Z)-5-({1-[2,4-bis(trifluoromethyl)benzyl]piperidin-4-yl}methylidene)-2-oxo-2,5-dihydro-1,3-thiazol-4-yl]glycinate 
• 1422128-10-6 N²-[(5Z)-5-({1-[2,4-bis(trifluoromethyl)benzyl]piperidin-4-yl}methylidene)-2-oxo-2,5-dihydro-1,3-thiazol-4-yl]-L-serinamide 
• 1422128-11-7 (5Z)-5-({1-[2,4-bis(trifluoromethyl)benzyl]piperidin-4-yl}methylidene)-4-(prop-2-yn-1-ylamino)-1,3-oxazol-2(5H)-one 
• 1422128-14-0 (5Z)-5-({1-[2,4-bis(trifluoromethyl)benzyl]piperidin-4-yl}methylidene)-4-{[(1R)-1-(hydroxymethyl)prop-2-yn-1-yl]amino}-1,3-thiazol-2(5H)-one 
• 1422127-07-8 C₂₄H₃₀F₆N₄OS 
• 1422128-21-9 (5Z)-5-({1-[2,4-bis(trifluoromethyl)benzyl]piperidin-4-yl}methylidene)-4-[(2-oxo-2-pyrrolidin-1-ylethyl)amino]-1,3-thiazol-2(5H)-one 
• 1422128-22-0 (5Z)-5-({1-[2,4-bis(trifluoromethyl)benzyl]piperidin-4-yl}methylidene)-4-[(2-morpholin-4-yl-2-oxoethyl)amino]-1,3-thiazol-2(5H)-one 
• 1422128-23-1 (5Z)-5-({1-[2,4-bis(trifluoromethyl)benzyl]piperidin-4-yl}methylidene)-4-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]amino-1,3-thiazol-2(5H)-one 
• 1422128-29-7 N²-[(5Z)-5-({1-[2,4-bis(trifluoromethyl)benzyl]piperidin-4-yl}methylidene)-2-oxo-2,5-dihydro-1,3-thiazol-4-yl]-N-(2-hydroxyethyl)-N-methylglycinamide 

Relevant articles and documents

Scavenger assisted combinatorial process for preparing libraries of tertiary amine compounds

This invention relates to a novel solution phase process for the preparation of tertiary amine combinatorial libraries. These libraries have utility for drug discovery and are used to form wellplate components of novel assay kits.

2-OXABICYCLO(2,2,1)HEPTANE DERIVATIVES AND PHARMACEUTICAL

The invention relates to 2-oxabicyclo[2.2.1]heptane derivatives of formula I (I) as well as their enantiomers, in which, e.g., A means -(CH2)n-, (E)- or (Z)-CH=CH-, -C 3BOND C, -O- or -S-, B means hydrogen, C1-C10 alkyl, -OR2, halogen, -C 3BOND N, -N3, -COOR3, R1 means oxygen or a -CH2 group, Z means -(CH2)p-, (E)-CH=CH-, -C 3BOND C-, W means a direct bond, a free or functionally modified hydroxymethylene group or a free or functionally modified in which the OH group can be respectively in alpha- or beta-position, D means a direct bond, a saturated alkylene group with 1-5 C atoms, a branched saturated or a straight-chain of branched unsaturated alkylene group with 2-5 C atoms, E means a direct bond, -C 3BOND C- or -CH=CR7, R8 means hydrogen, C1-C10 alkyl, C3-C10 cycloalkyl, optionally substituted C6-C12 aryl or a 5- or 6-member heterocyclic radical, and if R5 means hydrogen, their salts with physiologically compatible bases, as well as the alpha-, beta- or gamma-cyclodextrin clathrates, as well as the compounds of formula I encapsulated with liposomes, process for their production and the pharmaceutical agents containing these compounds. The compounds are thromboxane antagonists